U.S. Food and Drug Administration (USFDA) has completed inspection of J.B. Chemicals & Pharmaceuticals’ formulations manufacturing facility- T20 located at Plot No. 4, GIDC, Panoli, Gujarat. The inspection was conducted from March 3, 2025 to March 7, 2025. The said audit has been successfully completed by the USFDA with ‘No Observations’ and thus NO Form 483 was issued.
The company remains committed to producing quality products, embedding a quality culture across the organization and continuously investing in systems, processes & training of its employees so that it can maintain the highest standards of quality and compliance for all its markets.
J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs.
